TY  - JOUR
AU  - Raya, Pedro Mezquita
AU  - Blasco, Francisco Javier Ampudia
AU  - Hunt, Barnaby
AU  - Martin, Virginia
AU  - Thorsted, Brian Larsen
AU  - Basse, Amaury
AU  - Price, Hermione
PY  - 2019
DO  - 10.1111/dom.13660
UR  - http://hdl.handle.net/10668/13542
T2  - Diabetes, obesity & metabolism
AB  - To evaluate the long-term cost-effectiveness of fixed-ratio combination insulin degludec/liraglutide (IDegLira) versus comparator regimens for type 2 diabetes in Spain, based on real-world evidence. Clinical data were taken from the European Xultophy...
LA  - en
KW  - IDegLira
KW  - Spain
KW  - cost
KW  - cost-effectiveness
KW  - insulin
KW  - real-world evidence
KW  - type 2 diabetes
KW  - Cost-Benefit Analysis
KW  - Diabetes Complications
KW  - Diabetes Mellitus, Type 2
KW  - Drug Combinations
KW  - Humans
KW  - Hypoglycemic Agents
KW  - Insulin, Long-Acting
KW  - Liraglutide
KW  - Retrospective Studies
KW  - Spain
TI  - Evaluating the long-term cost-effectiveness of fixed-ratio combination insulin degludec/liraglutide (IDegLira) for type 2 diabetes in Spain based on real-world clinical evidence.
TY  - research article
VL  - 21
ER  -